# Transcript — Interview-first — clarifying questions before research starts / 访谈优先——研究开始前先提出澄清问题

- Scenario: `agent-interview-en` (kind: agent, lang: en)
- Outcome: **PASS**
- Session: 2026-09-11T13:31:14.409Z → 2026-09-11T13:31:47.415Z
- Replay: `node demos/run-demo.mjs --only agent-interview-en --publish` (spends LLM tokens; manual-run only)

## Prompt / 提示词

```text
Using the bioresearcher-deep-research skill, run a deep research report on CAR-T therapy safety in solid tumors.
```

## Tool calls (1) / 工具调用

### 1. `skill` — completed

Input:
```json
{"name":"bioresearcher-deep-research"}
```
Output (trimmed):
```text
<skill_content name="bioresearcher-deep-research">
# Skill: bioresearcher-deep-research

# Bioresearcher Deep Research

Reference-based biomedical research: interview the user to clarify scope and
align the research plan, split the topic into research aspects, investigate each
aspect with biomcp tools, then synthesize a succinct, accurately cited report.
Harness-agnostic: works with or without a subagent/Task tool.

## What it does

- Clarifies the research question and proposes a structured research plan
  with 2-5 independent aspects for user feedback before execution.
- Runs one focused worker per aspect - in parallel via the harness's
… [trimmed 409 more line(s)]
```

## Final answer (verbatim) / 最终回答（原文）

The skill's workflow requires a clarifying interview before research begins. Here are my questions:

**Step 1: Clarifying questions — CAR-T therapy safety in solid tumors**

1. **Safety scope**: Should the report cover the full adverse-event spectrum (CRS, ICANS, on-target/off-tumor toxicity, hematologic toxicity, long-term toxicities), or focus on specific events?
2. **Tumor types**: Any priority solid tumors (e.g., glioblastoma, pancreatic, ovarian, breast), or a pan-solid-tumor overview?
3. **Time frame**: Last 5 years only, or include the full historical record (early-generation trials onward)?
4. **Evidence base**: Clinical trials only (ClinicalTrials.gov + published results), or also include mechanistic/preclinical literature and FDA/EMA regulatory actions?
5. **Output depth**: Concise brief (~1,500 words) or full report (~3,000+ words with HTML)?

Please answer any or all — I'll propose a research plan next.
